Thromb Haemost 2013; 110(06): 1112-1113
DOI: 10.1160/TH13-10-0882
T&H Insight
Schattauer GmbH

miR-223: sailing to terra incognita for microRNAs in platelets

Julie Halkein
1   Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
,
Leon J. De Windt
1   Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands
2   Department of Cardiology, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands
› Author Affiliations
Further Information

Publication History

Received: 28 October 2013

Accepted: 28 October 2013

Publication Date:
30 November 2017 (online)

T&H Insight on: Leierseder et al. Thromb Haemost 2013; 110: 1207-1214.

 
  • References

  • 1 Leiderseider S. et al MiR-223 is dispensable for platelet production and function in mice. Thromb Haemost 2013; 110: 1207-1214.
  • 2 Willeit P. et al. Circulating microRNAs as novel biomarkers for platelet activation. Circulation Res 2013; 112: 595-600.
  • 3 Laffont B. et al. Activated platelets can deliver mRNA regulatory Ago2*microRNA complexes to endothelial cells via microparticles. Blood 2013; 122: 253-261.
  • 4 Felli N. et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009; 94: 479-486.
  • 5 Yuan JY. et al. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med 2009; 13: 4551-4559.
  • 6 Zampetaki A. et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol 2012; 60: 290-299.